Wordt geladen...
Using internally developed risk models to assess heterogeneity in treatment effects in clinical trials
BACKGROUND: Recent proposals suggest that risk-stratified analyses of clinical trials be routinely performed to better enable tailoring of treatment decisions to individuals. Trial data can be stratified using externally developed risk models (e.g. Framingham risk score), but such models are not alw...
Bewaard in:
| Hoofdauteurs: | , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2014
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3957096/ https://ncbi.nlm.nih.gov/pubmed/24425710 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCOUTCOMES.113.000497 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|